The CHK1 Inhibitor Prexasertib in BRCA Wild-Type Platinum-Resistant Recurrent High-Grade Serous Ovarian Carcinoma: a Phase 2 Trial

Request Access
dbGaP FAQdbGaP Access Request Video Tutorial
Platforms
dbGaP
View in dbGaP
phs003588.v1.p1
APIs
dbGaP FHIR
View in dbGaP

Consent Codes

Unspecified

Focus / Diseases

Ovarian Neoplasms

Study Design

Clinical Trial

Data Types

WXS

Subjects

18